GNPX
Genprex, Inc.Company Information
- Company Name
- Genprex, Inc.
- CIK
- CIK0001595248
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- GNPX: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- GNPX
SEC filing data through
Insider Sentiment
- Last purchase
- 2023-04-21
- Last sale
- 2026-04-14
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 8
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 226,300
- Shares outstanding
- 473,162
- Ownership
- 47.83%
Earnings Market Reaction
- Filing date
- 2026-08-14
- Price on filing date
- —
- 1-month reaction
- -18.98%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Cash Equivalents At Carrying Value | 15 | 18 | 8 | 1 | 1 | 3 | 2 | 1 | 2 | 8 | 7 | 12 | ||||||
Assets Current | ||||||||||||||||||
| Assets Current | 16 | 19 | 8 | 2 | 2 | 4 | 2 | 2 | 4 | 9 | 8 | 13 | ||||||
| Prepaid Expense And Other Assets Current | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 2 | 1 | 1 | 1 | ||||||
| Property Plant And Equipment Net | - | - | 0 | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Other Assets | ||||||||||||||||||
| Deposits Assets Noncurrent | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Other Assets Noncurrent | ||||||||||||||||||
| Other Assets Noncurrent | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 4 | ||||||
| Assets | 17 | 20 | 10 | 4 | 4 | 6 | 4 | 4 | 7 | 13 | 11 | 17 | ||||||
| Intangible Assets Net Excluding Goodwill | - | - | - | - | - | - | 0 | 0 | 0 | 1 | 1 | 1 | ||||||
| Accounts Payable And Accrued Liabilities Current | 0 | 2 | 1 | 2 | 1 | 2 | 1 | 1 | 1 | 2 | 1 | 1 | ||||||
Liabilities Current | ||||||||||||||||||
| Liabilities Current | 2 | 3 | 2 | 3 | 2 | 2 | 3 | 2 | 2 | 4 | 3 | 4 | ||||||
| Derivative Liabilities Current | 0 | - | - | - | - | - | - | - | - | - | - | - | ||||||
| Other Liabilities Current | 2 | 2 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 3 | ||||||
Liabilities Noncurrent | ||||||||||||||||||
| Derivative Liabilities | 0 | 0 | 0 | 0 | - | - | 0 | - | - | - | - | - | ||||||
| Derivative Liabilities Noncurrent | 0 | - | - | - | - | - | - | - | - | - | - | - | ||||||
| Liabilities | 2 | 3 | 2 | 3 | - | - | 3 | - | - | - | - | - | ||||||
| Accounts Receivable Net Current | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | 0 | 0 | ||||||
Stockholders Equity | ||||||||||||||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Stockholders Equity | 15 | 17 | 8 | 1 | 1 | 4 | 2 | 2 | 4 | 9 | 7 | 12 | ||||||
| Additional Paid In Capital | 195 | 192 | 179 | 168 | 165 | 163 | 156 | 152 | 150 | 148 | 141 | 140 | ||||||
| Retained Earnings Accumulated Deficit | -180 | -175 | -171 | -167 | -163 | -159 | -155 | -150 | -146 | -140 | -134 | -128 | ||||||
| Liabilities And Stockholders Equity | 17 | 20 | 10 | 4 | 4 | 6 | 4 | 4 | 7 | 13 | 11 | 17 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | ||||||
| Common Stock Shares Issued | 1 | 9 | 3 | 1 | 1 | 0 | 0 | 0 | - | 0 | 0 | 0 | ||||||
| Shares Outstanding | 1 | 9 | 3 | 1 | 28 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialGenprex, Inc. (GNPX) — SEC Financial Statements & Analysis
Genprex, Inc. (GNPX) is a pharmaceutical preparations company, incorporated in TX. Genprex, Inc. trades on Nasdaq as: GNPX. Genprex, Inc. (GNPX)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-14. Based on that filing, Genprex, Inc. carries a market cap of $5.40M, a P/E ratio of -0.33x, a P/B ratio of 0.37x, an enterprise value of $-9.75M, and an EV/EBITDA multiple of 0.62x. On profitability, it posts a Return on Equity (ROE) of -203.86%, a Return on Assets (ROA) of -157.40%, and a Return on Invested Capital (ROIC) of -20754.46%. Per share, it reports EPS of $-34.87, free cash flow per share of $-32.89, and a dividend per share of $0.00. Over the trailing year, it posted net income growth of -6.06% year-over-year and EPS growth of -94.99% year-over-year. On the balance sheet, it maintains a current ratio of 6.77x, a quick ratio of 6.47x, working capital of $13.50M, a debt-to-equity ratio of 0.16x, a debt ratio of 0.14, free cash flow of $-15.56M (TTM), and net debt of $-15.15M. Figures sourced from SEC EDGAR.
- Market Cap
- $5.40M
- P/E TTM
- -0.33x
- EPS TTM
- $-34.87
- P/B TTM
- 0.37x
- ROE TTM
- -203.86%
- ROA TTM
- -157.40%
- Debt To Equity
- 0.16x
- Free Cash Flow TTM
- $-15.56M
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Genprex, Inc. in?
Genprex, Inc. (GNPX) operates in the Pharmaceutical Preparations industry.
What exchange does GNPX trade on?
Genprex, Inc. (GNPX) trades on the Nasdaq.
Where is Genprex, Inc. incorporated?
Genprex, Inc. is incorporated in TX.
When was Genprex, Inc. (GNPX)'s most recent SEC filing?
Genprex, Inc. (GNPX)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-14.
What is GNPX's market cap?
Genprex, Inc. (GNPX) has a market capitalization of $5.40M as of 2026-06-30.
What is GNPX's EPS (earnings per share)?
Genprex, Inc. (GNPX)'s trailing twelve month EPS is $-34.87 as of 2026-06-30.
What is GNPX's ROE (return on equity)?
Genprex, Inc. (GNPX)'s trailing twelve month Return on Equity (ROE) is -203.86% as of 2026-06-30.
What is GNPX's ROA (return on assets)?
Genprex, Inc. (GNPX)'s trailing twelve month Return on Assets (ROA) is -157.40% as of 2026-06-30.
What is GNPX's ROIC (return on invested capital)?
Genprex, Inc. (GNPX)'s trailing twelve month Return on Invested Capital (ROIC) is -20754.46% as of 2025-12-31.
What is GNPX's EV/EBITDA?
Genprex, Inc. (GNPX)'s trailing twelve month EV/EBITDA is 0.62x as of 2026-06-30.